Genome British Columbia | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity	Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Unknown Primary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Unknown Primary Tumors, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, female reproductive organ cancer, head and neck cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm	Recruiting	Phase 2	2026-09-16		NCT04273061
Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada	Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, hereditary disease, laminopathy	Enrolling by invitation	Not applicable	2026-05-08		NCT07345338
Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System	Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions	Recruiting	Not stated	2026-05-01		NCT04249375
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children	Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions	Recruiting	Not stated	2026-05-01		NCT00414115
Epigenetic Health Benefits of Budesonide	Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis	Active, not recruiting	Phase 4	2025-03-27		NCT04342039
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood	Chromosome Aberrations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, aneuploidy	Active, not recruiting	Not applicable	2025-02-12		NCT03831256